Thus, the overactivation of the NLRP3 inflammasome in astrocytes has gained recognition as a key player in the neuroinflammatory pathology observed in PD, presenting potential therapeutic targets to mitigate disease progression. The gene discussed is NLRP3; the disease is Parkinson disease.